Abstract Details
Cole D. Libner
(Office of the MS Saskatchewan Clinical Research Chair)
PRESENTER |
Mr. Libner has received research support from Canadian Institutes of Health Research PhD Scholarship . |
No disclosure on file | |
Michael C. Levin, MD, FAAN (University of Saskatchewan) | Dr. Levin has received personal compensation for serving as an employee of Merck. Dr. Levin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Levin has received research support from CIHR. |